The institutional trading community now has a new option for achieving the fastest access to market data from the CME Group through a new collaboration between Celoxica and Born Technology.
The collaboration addresses the growing need for a comprehensive ultra-low latency market access solution to enable firms to compete in today's high-speed global markets.
The partnership will unite Born Technology's ultra-low latency infrastructure solutions and Celoxica's hardware-accelerated market data and order execution gateways to provide institutional traders with the tools they need to execute extremely latency-sensitive trading strategies.
"This partnership enhances both companies' core offerings and fits in perfectly with Celoxica's strategic direction, to allow firms to focus on their trading strategies while reducing their costs," says Celoxica CEO Jean-Marc Bouhelier. "We are excited to be working with Born to provide mutual clients with a robust, best of breed solution that offers them both the fastest, most reliable access to CME and a reduced time to market."
The partnership will provide improved CME Group access to an institutional clientele, including global banks, hedge and futures fund managers, international brokers and proprietary trading firms.
"We are delighted to partner with Celoxica, a global leader in low-latency solutions," says Born Technology president Derek Haworth. "Celoxica's proven trading solutions will complement Born Technology's infrastructure offering to better serve clients, as we continue to grow our global connectivity footprint. This aligns with our belief that faster connectivity and better execution benefits the trading community as a whole."
